Clinical Trials Genotype Immune Response Vaccination 
XTalks
SEPTEMBER 15, 2020
A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. Diamyd Medical is a clinical-stage biopharmaceutical company that develops therapies for type 1 diabetes.
Delveinsight
DECEMBER 13, 2020
This discovery led to the development of diagnostic tests and an effective vaccine, and Blumberg was awarded the Nobel Prize in Physiology or Medicine in 1976 for this discovery. Even though clinical trial results were promising, adverse events and serious complications were observed. and GT2 and GT3 with ribavirin.
Expert insights. Personalized for you.
103 
Let's personalize your content